@BarkingGecko good morning, just woken up. Great night last night watching Arsenal. BG you could not be more wrong. Keep your post as a reminder and I’ll make a note to contact you in 3 years and we can compare where we are as a share price compared to 1.50 now. Shorters will be running for cover. OTAT big green tick, our chronic back pain reduction potential has been acknowledged by the FDA ( no conspiracy theories now my shorting friends) and by the way this is just the start. Tide has turned and those holding a short position still have forgotten their trunks, waters have gone cold and we will see their packages shrivel . I am a LTH gave in 5 years minimum. 3 more to go and now these 20x-100 returns are back on. Let the shorters post what they want, no one will be listening. Now for a great Christmas all we need is a fight back in the Ashes. See even I can get carried away.
regards
A very happy Yelrom
- Forums
- ASX - By Stock
- Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
@BarkingGecko good morning, just woken up. Great night last...
-
- There are more pages in this discussion • 239 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | 1.485 |
5 | 59100 | 1.480 |
4 | 60253 | 1.475 |
3 | 35489 | 1.470 |
1 | 34513 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 73626 | 3 |
1.505 | 29500 | 2 |
1.510 | 41232 | 6 |
1.515 | 123153 | 3 |
1.520 | 81763 | 5 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
MSB (ASX) Chart |